| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criterion 6. See AWMSG criteria for appraising a medicine for information. |
|
Medicine details |
|
| Medicine name | peginterferon beta 1a (Plegridy®) |
| Formulation | 125 micrograms solution for injection |
| Reference number | 4721 |
| Indication | Treatment of relapsing remitting multiple sclerosis in adult patients |
| Company | Biogen Idec Ltd |
| BNF chapter | Malignant disease & immunosuppression |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 24/09/2020 |